Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity (Details) - Schedule of Options Granted to Purchase

v3.24.2.u1
Stockholders Equity (Details) - Schedule of Options Granted to Purchase - Stock Option [Member] - USD ($)
$ / shares in Units, $ in Thousands
 6 Months Ended
Jun. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Options, Outstanding at the beginning of period 5,280,711
Weighted Average Exercise Price, Outstanding at the beginning of period $ 0.54
Aggregate Intrinsic Value, Outstanding at the beginning of period $ 72
Number of Options, Granted
Weighted Average Exercise Price, Granted
Number of Options, Forfeited (206,231)
Weighted Average Exercise Price, Forfeited $ 0.4
Number of Options, Expired (3,066)
Weighted Average Exercise Price, Expired $ 0.41
Number of Options, Exercised
Weighted Average Exercise Price, Exercised
Number of Options, Outstanding at the end of period 5,071,414
Weighted Average Exercise Price, Outstanding at the end of period $ 0.55
Aggregate Intrinsic Value, Outstanding at the end of period $ 214
Number of Options, Exercisable at end of period 3,410,134
Weighted Average Exercise Price, Exercisable at the end of period $ 0.57
Weighted average remaining contractual life of outstanding options – years as of June 30, 2024 6 years 14 days